Investigation of Revance Therapeutics, Inc.
Revance Therapeutics, Inc. (RVNC) Misled Investors Regarding FDA Approval of its Lead Drug Candidate A class action was filed on behalf of all persons and entities that purchased or otherwise
Revance Therapeutics, Inc. (RVNC) Misled Investors Regarding FDA Approval of its Lead Drug Candidate A class action was filed on behalf of all persons and entities that purchased or otherwise
Organogenesis Holdings, Inc. (ORGO) Failed to Disclose the Truth About its High Prices and Product Reimbursements A class action was filed on behalf of all persons and entities that purchased
Paysafe Limited (PSFE) Failed to Disclose the Truth About its Business Prospects A class action was filed on behalf of all persons and entities that purchased or otherwise acquired Paysafe
Robinhood Markets, Inc. (HOOD) Made Material Misstatements in its Offering Documents in Support of its IPO A class action was filed on behalf of all persons and entities that purchased
Marathon Digital Holdings, Inc. (MARA) Violated U.S. Securities Laws A class action was filed on behalf of all persons and entities that purchased Marathon Digital Holdings, Inc. (NASDAQ: MARA)
Sleep Number Corporation (SNBR) Misled Investors Regarding its Supply Chain Flexibility A shareholder filed a class action on behalf of all purchasers of Sleep Number Corporation (NASDAQ: SNBR) common stock
Zhangmen Education Inc. (ZME) Made False and Misleading Statements in its Offering Materials Supporting its IPO A class action was filed on behalf of all persons and entities that
Exicure, Inc. (XCUR) Failed to Disclose Improprieties Associated with its Preclinical Program for the Treatment of Friedreich’s Ataxia A class action was filed on behalf of all persons and entities
Revance Therapeutics, Inc. (RVNC) Misled Investors Regarding FDA Approval of its Lead Drug Candidate A class action was filed on behalf of all persons and entities that purchased or otherwise
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.